BlackRock »

Immunovant shares owned by BlackRock

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $144M 5.1M 28.51

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Immunovant

Vanguard Group
BlackRock
BlackRock
Armistice Capital
T. Rowe Price Investment Management
Deep Track Capital
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant